Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
820.00    -11.00 (-1.32%)
Bid:
816.00
Ask:
822.00
Spread: 6.00 (0.735%)
Market Cap: £774.61m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AUM Update

11 Oct 2012 07:00

RNS Number : 3629O
Polar Capital Holdings PLC
11 October 2012
 



11 October 2012

 

Polar Capital Holdings plc

AUM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist asset management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM").

 

Group AUM (unaudited)

 

As at 30 September 2012 the Group's AUM increased by 4.3% to $5.30bn from the $5.08bn reported at 31 March 2012. This also represents a 34.5% increase in AUM from the $3.94bn reported at 30 September 2011.

 

The table below sets out the movements in the Group's AUM over the six month period:

 

AUM movement

Six months to 30 September 2012

Long only funds

$m

Hedge funds

$m

Total

$m

As at 31 March 2012

$4,365m

$718m

$5,083m

Net subscriptions

$371m

$34m

$405m

Market movement and performance

$(193)m

$7m

$(186)m

Total AUM at 30 September 2012

$4,543m

$759m

$5,302m

 

Comment

 

Polar Capital has received $405m of net inflows in its first half year, $31m of which in the last quarter. It is encouraging that, although there were market driven outflows from some of the Group's larger long only strategies, these were more than covered by inflows into a number of the Group's nascent long only strategies. In addition, positive net inflows into the Group's hedge fund products, which started in the previous quarter, continued to gain momentum in this quarter. Importantly, these flow patterns further enhance the continued diversification of the Group's offerings as well as reducing the firm's legacy concentration risk.

 

We consider that as the performance of the Group's products remains good, the Group is well positioned to continue to grow its assets under management over the approaching quarters, assuming that market conditions do not deteriorate further.

 

Net performance fees (unaudited)

 

The table below sets out the position relating to net performance fees (after the deduction of staff interests) earned and accrued in the first six months of the Group's financial year. The majority of the Group's performance fees crystallise in the second half of the financial year.

 

Performance fees

net of staff allocations

Six months to

30 Sept 11

£m

Year to

31 Mar 12

(year-end)

£m

Six months to

30 Sept 12

£m

Received

£1.5m

£4.1m

£0.0m

Accrued but not yet earned in funds with year ends on or before the financial year end

£1.6m

n/a

£4.2m

Total net performance fees

£3.1m

£4.1m

£4.2m

 

 

For further information please contact:

 

Polar Capital

Tim Woolley (CEO)John Mansell (CFO)

Canaccord Genuity - Nomad and Broker

Simon Bridges

Cameron Duncan

F T I Consulting

Ed Gascoigne-Pees

Jack Hickey

 

 

+44 (0)20 7227 2700

 

 

+44 (0)20 7523 8000

 

 

+44 (0)20 7269 7132

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAPEEFESAFEF
Date   Source Headline
4th Feb 20199:43 amRNSBlock listing Interim Review
1st Feb 201911:41 amRNSTotal Voting Rights
29th Jan 20194:41 pmRNSSecond Price Monitoring Extn
29th Jan 20194:35 pmRNSPrice Monitoring Extension
28th Jan 20195:45 pmRNSIssue of Equity
28th Jan 20195:30 pmRNSDirector/PDMR Shareholding
10th Jan 201910:19 amRNSDirector/PDMR Shareholding
10th Jan 20197:00 amRNSAUM Update
2nd Jan 20199:49 amRNSTotal Voting Rights
12th Dec 20184:00 pmRNSIssue of Equity
27th Nov 20184:40 pmRNSSecond Price Monitoring Extn
27th Nov 20184:35 pmRNSPrice Monitoring Extension
26th Nov 20187:00 amRNSUnaudited Interim Results
22nd Nov 20185:00 pmRNSDirectorate Change
5th Nov 20187:01 amRNSNotice of Results
5th Nov 20187:00 amRNSChange of Nominated Adviser and Broker
1st Nov 20187:00 amRNSTotal Voting Rights
25th Oct 20185:26 pmRNSIssue of Equity
24th Oct 20184:52 pmRNSDirector/PDMR Shareholding
17th Oct 20185:49 pmRNSIssue of Equity
15th Oct 201812:38 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
12th Oct 20182:52 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
11th Oct 20184:42 pmRNSIssue of Equity
11th Oct 20187:01 amRNSCrystallisation of business unit & issue of shares
11th Oct 20187:00 amRNSAUM Update
3rd Oct 201810:24 amRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
19th Sep 201811:52 amRNSForm 8.3 - Jardine Lloyd Thompson Group
18th Sep 201812:02 pmRNSForm 8.3 - Realm Therapeutics PLC
17th Aug 20189:27 amRNSDirectorate Change
6th Aug 20187:00 amRNSBlock listing Interim Review
1st Aug 20187:00 amRNSTotal Voting Rights
31st Jul 20185:57 pmRNSIssue of Equity
31st Jul 201811:29 amRNSDirector/PDMR Shareholding
25th Jul 20183:38 pmRNSDirectorate Change
25th Jul 20183:26 pmRNSResult of AGM
19th Jul 201811:13 amRNSForm 8.3 - Consort Medical Plc
18th Jul 20184:21 pmRNSDirector/PDMR Shareholding
18th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
17th Jul 201810:58 amRNSForm 8.3 - Consort Medical Plc
16th Jul 20183:44 pmRNSDirector/PDMR Shareholding
12th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
12th Jul 20187:00 amRNSAuM Update
11th Jul 201811:06 amRNSForm 8.3 - Consort Medical Plc
3rd Jul 20186:27 pmRNSHolding(s) in Company
3rd Jul 20186:20 pmRNSIssue of Equity
3rd Jul 201812:07 pmRNSForm 8.3 - Consort Medical Plc
2nd Jul 201810:23 amRNSTotal Voting Rights
29th Jun 20187:00 amRNSBlock Listing Application
28th Jun 20185:55 pmRNSAnnual Financial Report
25th Jun 20187:00 amRNSGroup Audited Results for year ended 31 March 2018

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.